Patents Issued in October 11, 2022
  • Patent number: 11466084
    Abstract: The application provides anti-PD-1 monoclonal antibodies, antigen binding portions thereof, therapeutic compositions thereof and/or nucleic acid encoding the same, and their use to upregulate the function of T-cells to enhance cell-mediated immune responses in the treatment of cancer and other T-cell dysfunctional disorders.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: October 11, 2022
    Assignee: SYSTIMMUNE, INC.
    Inventors: Brian Kovacevich, Dong Xia, Anne E. Jensen, Jonathan K. Fallen, Blair Renshaw, Jeffrey B. Adamo, Phil Tan, Zeren Gao, Yi Zhu
  • Patent number: 11466085
    Abstract: Provided in the present invention are a type of anti-human PD-L1 specific nanobodies and VHH chains thereof, coding sequences of the foregoing nanobodies or VHH chains thereof, corresponding expression vectors and host cells, and a method for producing antibodies.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: October 11, 2022
    Assignee: NANOMAB TECHNOLOGY LIMITED
    Inventors: Hong Hoi Ting, Chung Lim Wong
  • Patent number: 11466086
    Abstract: Disclosed is an isolated monoclonal antibody that specifically binds human 4-1BB, or the antigen-binding portion thereof. A nucleic acid molecule encoding the antibody, an expression vector, a host cell and a method for expressing the antibody are also provided. The present disclosure further provides a bispecific molecule, and a pharmaceutical composition comprising the antibody or the bispecific molecule, as well as a treatment method using an anti-4-1BB antibody of the disclosure.
    Type: Grant
    Filed: September 30, 2020
    Date of Patent: October 11, 2022
    Assignee: Nanjing Leads Biolabs Co., Ltd.
    Inventors: Xiaoqiang Kang, Xiao Huang, Jianming Sun
  • Patent number: 11466087
    Abstract: The present invention relates to anti-CLL-1 antibodies including anti-CLL-1 antibodies comprising a CLL-1 binding domain and a CD3 binding domain (e.g., anti-CLL-1/CD3 T cell dependent bispecific (TDB) antibody) and methods of using the same.
    Type: Grant
    Filed: October 21, 2019
    Date of Patent: October 11, 2022
    Assignee: Genentech, Inc.
    Inventors: Robert F. Kelley, Steven R. Leong, Wei-Ching Liang, Mary Mathieu, Andrew G. Polson, Bing Zheng, Xiaocheng Chen, Cecilia Pui Chi Chiu, Mark S. Dennis, Allen Ebens, Yan Wu
  • Patent number: 11466088
    Abstract: Compositions and methods for treating cancer in humans are provided using CARs. The invention includes engineered CARs (chimeric receptor antigens) and genetically modified immune cells that express such a CAR with a high affinity for VEGFR. More specifically, the cells are CAR-T cells recognizing VEGFR-2 on solid tumors, uses thereof, compositions thereof and methods of making. The invention includes therapeutic methods to treat VEGFR-2 dependent cancers targeting tumor angiogenesis. A chimeric antigen receptor (CAR) that binds to VEGFR-2, an epitope or fragment thereof, or a variant thereof.
    Type: Grant
    Filed: January 4, 2018
    Date of Patent: October 11, 2022
    Assignee: Helix BioPharma Corp.
    Inventors: Heman Lap Man Chao, Wah Yau Wong, Baomin Tian, Marni Diane Uger
  • Patent number: 11466089
    Abstract: The present invention relates to polypeptides directed against or specifically binding to C—X—C Motif chemokine receptor 2 (CXCR2) and in particular to polypeptides capable of modulating signal transduction from CXCR2. The invention also relates to nucleic acids, vectors and host cells capable of expressing the polypeptides of the invention, pharmaceutical compositions comprising the polypeptides and uses of said polypeptides and compositions for treatment of diseases involving aberrant functioning of CXCR2.
    Type: Grant
    Filed: June 26, 2017
    Date of Patent: October 11, 2022
    Assignee: Ablynx N.V.
    Inventors: Zarin Brown, Michelle Bradley, Steven John Charlton, Gino Anselmus Van Heeke, Karen Cromie, Bruno Dombrecht, Soren Steffensen, Judith Baumeister, Marie-Paule Bouche, Carlo Boutton, Marie-Ange Buyse, Veerle Snoeck, Stephanie Staelens
  • Patent number: 11466090
    Abstract: The present invention relates to methods of migraine prophylaxis using anti-CGRP receptor antibodies or binding fragments. In particular, methods for preventing or reducing the occurrence of migraine headache in a patient in need thereof comprising administering to the patient an anti-CGRP receptor or binding fragment according to specific dosage regimens are disclosed. Pharmaceutical compositions and administration devices comprising anti-CGRP receptor antibodies or binding fragments for use in the methods are also described.
    Type: Grant
    Filed: February 27, 2019
    Date of Patent: October 11, 2022
    Assignee: AMGEN INC.
    Inventors: Hong Sun, Eduardo Dunayevich, Robert A. Lenz, Gabriel Vargas
  • Patent number: 11466091
    Abstract: Methods of treating autoimmune diseases, such as primary immune thrombocytopenia (ITP), solid organ transplant rejection, graft-related disease, pemphigus vulgaris, systemic sclerosis, and myasthenia gravis using antibody polypeptides that specifically bind human CD40L are provided. The antibody polypeptides do not activate platelets. The methods may comprise at least one administration cycle comprising one dose of the antibody polypeptide. The dose may be administered intravenously at a dose from about 75 mg to about 1500 mg. The method normalizes platelet counts in the human patient.
    Type: Grant
    Filed: February 20, 2020
    Date of Patent: October 11, 2022
    Assignee: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Marek Honczarenko, Vaishali Shah, Lixin Lang, Urvi Aras, Diane Shevell, Christine Kratt, Karen Price, Suzanne Suchard
  • Patent number: 11466092
    Abstract: Provided herein are antibodies, or antigen binding portions thereof, that bind to OX40. Also provided are uses of these proteins in therapeutic applications, such as in the treatment of cancer. Further provided are cells that produce the antibodies, polynucleotides encoding the heavy and/or light chain variable region of the antibodies, and vectors comprising the polynucleotides encoding the heavy and/or light chain variable region of the antibodies.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: October 11, 2022
    Assignee: Bristol-Myers Squibb Company
    Inventors: Zhehong Cai, Indrani Chakraborty, Marie-Michelle Navarro Garcia, Thomas D. Kempe, Alan J. Korman, Alexander T. Kozhich, Hadia Lemar, Mark Maurer, Christina Maria Milburn, Michael Quigley, Xiang Shao, Mohan Srinivasan, Kent Thudium, Susan Chien-Szu Wong, Jochem Gokemeijer, Xi-Tao Wang, Han Chang, Patrick Guirnalda
  • Patent number: 11466093
    Abstract: Antibody derivatives that have diminished effector function in the initial state owing to the presence of one or more disabling moieties that substantially prevent engagement of the antibody regions responsible for interaction with humoral and cellular immune system effector molecules, and methods of use thereof.
    Type: Grant
    Filed: July 27, 2016
    Date of Patent: October 11, 2022
    Assignee: The General Hospital Corporation
    Inventors: Glen S. Cho, Brian Seed
  • Patent number: 11466094
    Abstract: The invention provides methods of dosing for the treatment of cancers, such as B cell proliferative disorders, with anti-cluster of differentiation 20 (CD20)/anti-cluster of differentiation 3 (CD3) bispecific antibodies.
    Type: Grant
    Filed: November 15, 2017
    Date of Patent: October 11, 2022
    Assignee: Genentech, Inc.
    Inventors: Yu-Waye Chu, Iraj Hosseini, Saroja Ramanujan, Kapil Gadkar, Chi-Chung Li
  • Patent number: 11466095
    Abstract: Novel anti-cancer agents, including, but not limited to, antibodies and immunoconjugates, that bind to CD37 are provided. Methods of using the agents, antibodies, or immunoconjugates, such as methods of inhibiting tumor growth are further provided.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: October 11, 2022
    Inventors: Jutta Deckert, Peter Park, Daniel Tavares, Lingyun Rui
  • Patent number: 11466096
    Abstract: Antibodies that include a sulfatase motif-containing tag in a constant region of an immunoglobulin (Ig) heavy chain polypeptide are disclosed. The sulfatase motif can be converted by a formylglycine-generating enzyme (FGE) to produce a formylglycine (fGly)-modified Ig heavy chain polypeptide. An fGly-modified Ig heavy chain polypeptide of the antibody can be covalently and site-specifically bound to a moiety of interest to provide an antibody conjugate. The disclosure also encompasses methods of production of such tagged Ig heavy chain polypeptides, fGly-modified Ig heavy chain polypeptides, and antibody conjugates, as well as methods of use of same.
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: October 11, 2022
    Assignee: R.P. Scherer Technologies, LLC
    Inventors: Yun Cheol Kim, Chao Bai Huang, Penelope M. Drake, David Rabuka
  • Patent number: 11466097
    Abstract: Chimeric transmembrane immunoreceptors (CAR) targeted to PSCA are described.
    Type: Grant
    Filed: October 6, 2016
    Date of Patent: October 11, 2022
    Assignee: City of Hope
    Inventors: Saul J. Priceman, Christine E. Brown, Stephen J. Forman
  • Patent number: 11466098
    Abstract: The present disclosure relates to specific binding agents binding to different PIVKA-II forms as compared to antibodies known so far in the art. The present disclosure also relates to methods of using the specific binding agents to detect the presence of PIVKA-II.
    Type: Grant
    Filed: January 13, 2020
    Date of Patent: October 11, 2022
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Bernhard Eckert, Michael Gerg, Johann Karl, Martin Kaufmann, Julia Riedlinger, Magdelena Swiatek-de Lange, Lars Hillringhaus, Klaus Hirzel, Marcus-Rene Lisy
  • Patent number: 11466099
    Abstract: Anti-nicotinamide phosphoribosyltransferase (NAMPT) antibodies, or antigen binding fragments thereof, are described, as well as methods for treating a subject having a (NAMPT)-associated local and/or systemic inflammatory disorder.
    Type: Grant
    Filed: October 11, 2021
    Date of Patent: October 11, 2022
    Assignee: Aqualung Therapeutics Corp.
    Inventors: Joe G. N. Garcia, Darragh Maccann
  • Patent number: 11466100
    Abstract: The present invention provides a novel method for producing carboxymethylated cellulose, the method making it possible to economically obtain a high-transparency cellulose nanofiber dispersion. In the carboxymethylation of cellulose, mercerization is carried out in a solvent comprising mainly water, and then carboxymethylation is carried out in a mixed solvent of water and an organic solvent. A nanofiber dispersion of high-transparency carboxymethylated cellulose can be obtained by defibrating the resulting carboxymethylated cellulose.
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: October 11, 2022
    Assignee: NIPPON PAPER INDUSTRIES CO., LTD.
    Inventors: Kazuhiko Inoue, Takeshi Nakatani, Yusuke Tada
  • Patent number: 11466101
    Abstract: Self-invertible inverse latex including as an inverting agent for surfactant species of the alkylpolyglycoside family, the alkyl chain of which includes from 8 to 18 carbon atoms, and use thereof as thickener and/or emulsifier and/or stabilizer for a detergent or cleaning formulation for industrial or household use.
    Type: Grant
    Filed: November 16, 2018
    Date of Patent: October 11, 2022
    Assignee: SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC
    Inventors: Miruna Bodoc, Georges Dacosta, Jérôme Guilbot, Aurélie Pierre
  • Patent number: 11466102
    Abstract: The present disclosure provides methods for producing an olefin polymer by contacting a C3-C40 olefin, ethylene and a diene with a catalyst system including an activator and a metallocene catalyst compound comprising a substituted or unsubstituted indacenyl group and obtaining a C3-C40 olefin-ethylene-diene terpolymer typically comprising from 30 to 55 mol % ethylene, from 69.09 to 45 mol % C3 to C40 comonomer, and from 0.01 to 7 mol % diene wherein the Tg of the terpolymer is ?28° C. or less. Preferably, a propylene-ethylene-ethylidene norbornene is obtained.
    Type: Grant
    Filed: December 14, 2020
    Date of Patent: October 11, 2022
    Assignee: ExxonMobil Chemical Patents Inc.
    Inventors: Jo Ann M. Canich, John R. Hagadorn, Rhutesh K. Shah, Florin Barsan, Sarah J. Mattler, Chase A. Eckert, Zhifeng Bai
  • Patent number: 11466103
    Abstract: A method for providing particles of polyvinyl chloride, wherein the particles offer improved chlorinating efficiency, the method comprising (i) providing polyvinyl chloride particles; and (ii) introducing a chlorination accelerant to the polyvinyl chloride particles to thereby provide polyvinyl chloride particles having an accelerant associated therewith.
    Type: Grant
    Filed: March 7, 2017
    Date of Patent: October 11, 2022
    Assignee: Oxy Vinyls, LP
    Inventors: Keith S. Kramer, Lance Mayer, Rodney L. Klausmeyer
  • Patent number: 11466104
    Abstract: Polymerization processes and reactor systems for producing multimodal ethylene polymers are disclosed in which at least one loop reactor and at least one fluidized bed reactor are utilized. Configurations include a loop reactor in series with a fluidized bed reactor and two loop reactors in series with a fluidized bed reactor.
    Type: Grant
    Filed: April 20, 2022
    Date of Patent: October 11, 2022
    Assignee: Chevron Phillips Chemical Company LP
    Inventors: Joel A. Mutchler, Eric J. Netemeyer, Joseph A. Curren, Michael H. Treptau, Kenneth A. Dooley, Jeffrey S. Lowell, Jeffrey S. Fodor, Scott E. Kufeld
  • Patent number: 11466105
    Abstract: The present invention relates to a photocurable acrylic resin which is a polymer of a monomer mixture including a crosslinkable monomer represented by [Formula 1]; a (meth)acrylic monomer including a photoinitiating functional group; and an alkyl (meth)acrylate-based monomer, and has a weight average molecular weight of 100,000 to 500,000, and a branch-type polymer structure, and an adhesive composition and an adhesive film including the same.
    Type: Grant
    Filed: October 24, 2018
    Date of Patent: October 11, 2022
    Inventors: Min Ki Lee, Jung Eun Woo, Kee Young Kim
  • Patent number: 11466106
    Abstract: A latex of an acid-modified conjugated diene polymer including the acid-modified conjugated diene polymer obtained by modifying a conjugated diene polymer with an acid group-containing compound, in which a content of a structural unit derived from the acid group-containing compound is 0.2 to 0.7 parts by weight with respect to 100 parts by weight of the acid-modified conjugated diene polymer; a content of a water-soluble polymer in the latex is 2 parts by weight or less with respect to 100 parts by weight of the acid-modified conjugated diene polymer; when a solids content of the latex is adjusted to 60 wt %, a viscosity at 25° C. is 800 mPa·s or less; and when the solids content of the latex is adjusted to 50 wt %, the viscosity at 25° C. is 300 mPa·s or less.
    Type: Grant
    Filed: February 22, 2019
    Date of Patent: October 11, 2022
    Assignee: ZEON CORPORATION
    Inventors: Yoshitaka Satoh, Hidetake Ishii, Junji Kodemura
  • Patent number: 11466107
    Abstract: A solid catalyst component for the polymerization of olefins CH2?CHR, wherein R is hydrogen or a hydrocarbon radical with 1-12 carbon atoms, made from or containing Mg, Ti, Bi, a halogen and an electron donor.
    Type: Grant
    Filed: January 25, 2019
    Date of Patent: October 11, 2022
    Assignee: Basell Poliolefine Italia S.r.l.
    Inventors: Simona Guidotti, Dario Liguori, Giampiero Morini, Gianni Vitale
  • Patent number: 11466108
    Abstract: Polymerization processes for producing ethylene-based plastomers and elastomers having densities less than 0.91 g/cm3 utilize a metallocene-based catalyst system containing a chemically-treated solid oxide. These polymerization processes can be conducted in a slurry reactor, a solution reactor, and/or a gas phase reactor. Ethylene polymers produced from the polymerization process can be characterized by a density of less than 0.91 g/cm3, a CY-a parameter of less than 0.2, and a ratio of HLMI/MI of at least 30, or a density less than 0.91 g/cm3, a CY-a parameter from 0.25 to 0.75, and a ratio of Mw/Mn from 2 to 3.
    Type: Grant
    Filed: February 22, 2022
    Date of Patent: October 11, 2022
    Assignee: Chevron Phillips Chemical Company LP
    Inventors: Scott E. Kufeld, Max P. McDaniel
  • Patent number: 11466109
    Abstract: The present invention relates to an amorphous functionalized olefin copolymer composition and a process for the preparation of an amorphous functionalized olefin copolymer composition.
    Type: Grant
    Filed: December 24, 2018
    Date of Patent: October 11, 2022
    Assignee: SABIC GLOBAL TECHNOLOGIES B.V.
    Inventors: Miloud Bouyahyi, Lidia Jasinska-Walc, Robbert Duchateau, Marc Tellez Nogales, Jakub Kruszynski, Tatani Aikaterini
  • Patent number: 11466110
    Abstract: The present invention relates to a semi-crystalline polyolefinic ionomer and a process for the preparation of a semi-crystalline polyolefinic ionomer.
    Type: Grant
    Filed: December 24, 2018
    Date of Patent: October 11, 2022
    Assignee: SABIC GLOBAL TECHNOLOGIES B.V.
    Inventors: Lidia Jasinska-Walc, Robbert Duchateau, Miloud Bouyahyi, Anton Ginzburg, Enrico Troisi
  • Patent number: 11466111
    Abstract: Embodiments provide a coating material containing: (A) 100 parts by mass of an acrylic curable resin; (B) 5-200 parts by mass of aluminum oxide particles having an average particle size of 1-100 ?m; (C) 0.1-20 parts by mass of aluminum oxide fine particles having an average particle size of 1-100 nm; and (D) 1-100 parts by mass of a compound having two or more isocyanate groups per molecule. In one embodiment, the acrylic curable resin (A) includes: (a1) a structural unit derived from a hydroxy group-containing (meth)acrylic acid ester; (a2) a structural unit derived from a vinyl aromatic compound; and (a3) a structural unit derived from a (meth)acrylic acid alkyl ester. In one embodiment, the acrylic curable resin (A) may contain, in addition to the structural units (a1) and (a2): (a3-1) a structural unit derived from methyl methacrylate; and (a3-2) a structural unit derived from an aliphatic (including alicyclic) alkyl ester having 4 or more carbon atoms of a (meth)acrylic acid.
    Type: Grant
    Filed: November 14, 2017
    Date of Patent: October 11, 2022
    Inventors: Shigekazu Ito, Koji Inagaki
  • Patent number: 11466112
    Abstract: Provided is a carboxylic acid-modified nitrile-based copolymer latex, and more particularly, provided are a carboxylic acid-modified nitrile-based copolymer latex which includes a carboxylic acid-modified nitrile-based copolymer including a monomer-derived repeating unit; and a repeating unit derived from a monomer represented by Chemical Formula 1 below, the monomer-derived repeating unit including a conjugated diene-based monomer-derived repeating unit, an ethylenically unsaturated nitrile-based monomer-derived repeating unit, and an ethylenically unsaturated acid monomer-derived repeating unit (see description of the present invention), a method for preparing a carboxylic acid-modified nitrile-based copolymer latex, a latex composition for dip-forming including the copolymer latex, and an article formed by the composition.
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: October 11, 2022
    Inventors: Ji Hyun Kim, Jung Eun Kim, Yong Seok Jung
  • Patent number: 11466113
    Abstract: Provided is a composition with which a film having reduced color unevenness can be formed. In addition, provide are a film, an infrared transmitting filter, a solid image pickup element, an image display device, and an infrared sensor. The composition including a light shielding material; and a compound A having a weight-average molecular weight of 3000 or higher that has a radically polymerizable ethylenically unsaturated group, in which the compound A includes a repeating unit having a graft chain, and a ratio Amin/Bmax of a minimum value Amin of an absorbance of the composition in a wavelength range of 400 to 640 nm to a maximum value Bmax of an absorbance of the composition in a wavelength range of 940 to 1300 nm is 5 or higher.
    Type: Grant
    Filed: July 18, 2019
    Date of Patent: October 11, 2022
    Assignee: FUJIFILM Corporation
    Inventors: Masahiro Mori, Akio Mizuno, Kazuya Oota
  • Patent number: 11466114
    Abstract: A composition for forming a phase-separated structure contains a block copolymer having a block (b1) consisting of a repeating structure of a styrene unit and a block (b2) consisting of a repeating structure of a methyl methacrylate unit, in which the block (b2) is disposed at least at one terminal portion of the block copolymer, the block copolymer has a structure (e1) represented by General Formula (e1) at least at one main chain terminal, and the structure (e1) is bonded to the main chain terminal of the block (b2) disposed at a terminal portion of the block copolymer. Ree0 represents a hydrocarbon group containing a hetero atom, and Re1 represents a hydrogen atom or a halogen atom.
    Type: Grant
    Filed: May 19, 2020
    Date of Patent: October 11, 2022
    Assignees: TOKYO OHKA KOGYO CO., LTD., NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
    Inventors: Ken Miyagi, Takahiro Dazai, Toshifumi Satoh, Takuya Isono
  • Patent number: 11466115
    Abstract: A porous membrane includes a triblock copolymer of the formula ABC. B is a hydrogenated vinyl aromatic block present in a range from 30 to 90 weight percent, based on the total weight of the copolymer and has a Tg of ?110° C. C is a rubbery block present in a range from 10 to 70 weight percent, based on the total weight of the copolymer and has a Tg?25° C. A is substantially incompatible with both the B and C blocks and is derived from ring-opening polymerization. B+C is present in a range from 70 to 95 weight percent, based on the total weight of the copolymer.
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: October 11, 2022
    Assignee: 3M Innovative Properties Company
    Inventors: Michelle M. Mok, Lucas D. McIntosh, Carl A. Laskowski, Timothy M Gillard
  • Patent number: 11466116
    Abstract: The present invention relates to a polyurethane, which is particularly suitable as binder for a printing ink, which is obtainable by reacting: a) a polyol component including: i) at least one polytetramethylene glycol, ii) at least one diol having a molecular weight of not more than 200 g/mol being different from polytetramethylene glycol, iii) at least one trivalent or higher-valent alcohol having a molecular weight of not more than 6000 g/mol, b) an isocyanate component including at least one organic diisocyanate compound and c) at least one di-functional amine compound and at least one mono-functional amine compound.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: October 11, 2022
    Assignee: HUBERGROUP ITALIA
    Inventors: Lutz Frischmann, Ursula Borgmann, Giuseppe Ciriello, Sylvia Klausnitzer, Vijay Wagh
  • Patent number: 11466117
    Abstract: The invention relates to a binder based on phenolic resins of the benzyl ether type and isocyanate compounds having at least two isocyanate groups, containing free phenol and free hydroxybenzyl alcohols in the polyol component. The invention further relates to mold material mixtures containing the binder and to cores, molds, or risers produced with the mold material mixtures and to the use thereof in metal casting.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: October 11, 2022
    Assignee: ASK Chemicals GmbH
    Inventors: Christian Priebe, Philipp Schneider, Mark Stancliff, Brian Weaver
  • Patent number: 11466118
    Abstract: A terminal hydroxyl functionalized polyfarnesene is provided. The polyfarnesene has more than two terminal hydroxyl groups per molecule, on average, based on the number average molecular weight. The polyfarnesenes may be homopolymers or copolymers of farnesene. Also provided is a method of making these polyfarnesenes having more than two hydroxyl groups per molecule. A composition for making a polyurethane comprising a diisocyanate and the terminal hydroxyl functionalized polyfarnesene is also provided.
    Type: Grant
    Filed: November 22, 2019
    Date of Patent: October 11, 2022
    Assignee: FINA TECHNOLOGY, INC.
    Inventors: Herbert Chao, Tomas Trnka
  • Patent number: 11466119
    Abstract: An epoxy resin, comprising an epoxy compound having a mesogenic structure, the epoxy compound comprising a first epoxy compound having one biphenyl structure in a molecule and a second epoxy compound that is different from the first epoxy compound, at a mass ratio of the first epoxy compound to the second epoxy compound (first epoxy compound:second epoxy compound) of from 10:100 to 50:100.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: October 11, 2022
    Assignee: Showa Denko Materials Co., Ltd.
    Inventors: Kazumasa Fukuda, Yoshitaka Takezawa, Naoki Maruyama, Yuka Yoshida, Tomoko Higashiuchi
  • Patent number: 11466120
    Abstract: A medical material comprising film obtained from a polyester wherein the polyester has a weight average molecular weight of 1,250,000 or greater determined by gel permeation chromatography calibrated with polystyrene standards. The polyester comprises a 3-hydroxybutyrate unit and a 4-hydroxybutyrate unit as polymerization units, and proportion of the 4-hydroxybutyrate unit relative to all monomer units is from 14 mol % to 40 mol %. The polyester film is useful for medical apparatus, packaging material for food, plastic sheet for agriculture, flowerpots for seedings, and sheets for construction and engineering.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: October 11, 2022
    Assignee: MITSUBISHI GAS CHEMICAL COMPANY, INC.
    Inventor: Akira Maehara
  • Patent number: 11466121
    Abstract: Provided herein according to aspects of the present invention are resins that: (a) are suitable for use in additive manufacturing techniques such as bottom-up and top-down stereolithography, (b) produce objects that are bioresorbable, and (c) produce objects that are flexible or elastic (preferably at at least typical room temperatures of 25° C., and in some embodiments at typical human body temperatures of 37° C.). Such resins may include: (a) a bioresorbable polyester oligomer having reactive end groups; (b) non-reactive diluent; (c) optionally reactive diluent; and (d) a photoinitiator.
    Type: Grant
    Filed: September 16, 2020
    Date of Patent: October 11, 2022
    Assignee: Carbon, Inc.
    Inventors: Xinyu Gu, Sharon Chen, Gina Michelle Policastro, Peyton Hopson, Jackie Donners, Michael Vendely, Jason L. Harris
  • Patent number: 11466122
    Abstract: This invention relates to odor control molecules comprised of polyethyleneimine compounds containing N-halamine and derivatives thereof.
    Type: Grant
    Filed: October 2, 2019
    Date of Patent: October 11, 2022
    Inventors: Sudhanshu Srivastava, Wesley A. Freund, Sanjeev K. Dey, Dominick J. Valenti
  • Patent number: 11466123
    Abstract: The resin composition of the present invention is a resin composition containing: a bismaleimide compound (A) containing a constituent unit represented by the following formula (1) and maleimide groups at both ends of the molecular chain; a compound (B) containing one or more carboxy groups; and a photo initiator (C). In the formula (1), R1 represents a linear or branched alkylene group having 1 to 16 carbon atoms, or a linear or branched alkenylene group having 2 to 16 carbon atoms. R2 represents a linear or branched alkylene group having 1 to 16 carbon atoms, or a linear or branched alkenylene group having 2 to 16 carbon atoms. Each R3 independently represents a hydrogen atom, a linear or branched alkyl group having 1 to 16 carbon atoms, or a linear or branched alkenyl group having 2 to 16 carbon atoms. Each n independently represents an integer of 1 to 10.
    Type: Grant
    Filed: June 26, 2020
    Date of Patent: October 11, 2022
    Assignee: MITSUBISHI GAS CHEMICAL COMPANY, INC.
    Inventors: Yune Kumazawa, Takuya Suzuki, Seiji Shika, Shunsuke Katagiri
  • Patent number: 11466124
    Abstract: A polyimide precursor composition according to the present invention enables alleviation of thermal expansion-contraction properties of a polyimide film resultingly prepared, by means of using siloxane-based diamine having a particular structure and a solvent having a positive partition coefficient. And the present invention enables excellent transparency, heat resistance, mechanical strength and flexibility and effective reduction of residual stress, and thus can be used in various fields such as a substrate for a device, a cover substrate for a display, an optical film, an integrated circuit (IC) package, an adhesive film, a multi-layer flexible printed circuit (FPC), tape, a touch panel and a protective film for an optical disk.
    Type: Grant
    Filed: July 9, 2018
    Date of Patent: October 11, 2022
    Assignee: LG CHEM, LTD.
    Inventors: Cheolmin Yun, Kyungjun Kim
  • Patent number: 11466125
    Abstract: Polythioether prepolymers that have a low nucleation temperature. The symmetry of the polythioether prepolymers is modified by including pendent groups extending from the backbone of the polythioether prepolymer chain and/or the symmetry is modified by including segments having a different number of —C(R)2— groups between heteroatoms. The polythioether prepolymers are stable at low temperature storage conditions for an extended period of time. Compositions prepared using the low nucleation temperature polythioether prepolymers are useful as sealants.
    Type: Grant
    Filed: December 19, 2019
    Date of Patent: October 11, 2022
    Assignee: PRC-DESOTO INTERNATIONAL, INC.
    Inventor: Chandra Rao
  • Patent number: 11466126
    Abstract: A condensation curable silicone adhesive composition comprising a siloxane-imide base polymer, condensation curable organopolysiloxane crosslinker, a condensation catalyst and an additive is shown and described herein. The composition is curable at relatively room temperatures and shows good heat stability.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: October 11, 2022
    Assignee: Momentive Performance Materials Inc.
    Inventors: Subrata Mandal, Tetsuo Fujimoto, Debanga B. Konwar
  • Patent number: 11466127
    Abstract: [Problem] To provide a novel polymer, which fills trenches having narrow widths and high aspect ratios and can form a thicker film. [Means for Solution] The block copolymer comprises a linear or cyclic block A having a polysilane skeleton comprising 5 or more silicon and a block B having a polysilazane skeleton comprising 20 or more silicon.
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: October 11, 2022
    Assignee: MERCK PATENT GMBH
    Inventors: Takashi Fujiwara, Yuji Tashiro
  • Patent number: 11466128
    Abstract: A superabsorbent polymer having optimized gel strength and exhibiting an improved absorption rate without increasing a specific surface area by chemical foaming or a physical method, and a preparation method thereof, are provided.
    Type: Grant
    Filed: June 11, 2019
    Date of Patent: October 11, 2022
    Inventors: Yong Hun Lee, Mookon Kim, Dae Woo Nam, Hyemi Nam, Sang Gi Lee, Chang Hun Lee, Jiyoon Jeong, Chang Hun Han
  • Patent number: 11466129
    Abstract: A method for producing a synthetic rubber, the method including: an emulsification step of continuously feeding a solution or a dispersion of a synthetic rubber obtained by dissolving or dispersing the synthetic rubber in an organic solvent and an aqueous solution of an emulsifier to a mixer and mixing to continuously obtain an emulsion; a first removal step of removing the organic solvent from the emulsion continuously obtained in the emulsification step in a container while the emulsion is continuously transferred to the container regulated to a pressure condition of 700 to 760 mmHg; and a second removal step of removing the organic solvent from the emulsion that has undergone the first removal step under a pressure of less than 700 mmHg.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: October 11, 2022
    Assignee: ZEON CORPORATION
    Inventors: Junji Kodemura, Yoshitaka Satoh
  • Patent number: 11466130
    Abstract: A fiber-reinforced polymer composition that comprises a polymer matrix; a thermally conductive filler distributed within the polymer matrix; and a plurality of long fibers distributed within the polymer matrix is provided. The long fibers comprise an electrically conductive material and have a length of about 7 millimeters or more. Further, the composition exhibits an in-plane thermal conductivity of about 1 W/m-K or more as determined in accordance with ASTM E 1461-13 and an electromagnetic shielding effectiveness of about 20 dB or more as determined at a frequency of 1 GHz in accordance with EM 2107A.
    Type: Grant
    Filed: November 14, 2018
    Date of Patent: October 11, 2022
    Assignee: Ticona LLC
    Inventor: Darin Grinsteinner
  • Patent number: 11466131
    Abstract: Provided are a superabsorbent polymer and a preparation method thereof, including preparing a base resin and conducting surface modification of the base resin in the presence of an inorganic filler. The method of preparing the superabsorbent polymer of the present invention may provide a superabsorbent polymer having improved rewetting property and liquid permeability.
    Type: Grant
    Filed: September 17, 2019
    Date of Patent: October 11, 2022
    Inventors: Young Jae Hur, Dae Woo Nam, Bohee Park, Sujin Kim
  • Patent number: 11466132
    Abstract: A sheet formed from carbon fiber reinforced thermoplastic resin with high heat resistance, and a production method of said sheet is provided. This sheet is formed from a carbon fiber reinforced thermoplastic resin that contains carbon fibers, dichloromethane, and a thermoplastic resin containing at least one of a polycarbonate resin and a polyarylate resin. The aforementioned at least one of a polycarbonate resin and a polyarylate resin has a constituent unit derived from a dihydric phenol represented by formula (1), and the content of the dichloromethane contained in the sheet is 10-10,000 ppm by mass. (In formula (1), R1-R4 independently represent a hydrogen, a halogen, a nitro, or a methyl group; X represents a divalent group represented by any of formulas (2) to (4).
    Type: Grant
    Filed: May 14, 2018
    Date of Patent: October 11, 2022
    Assignee: MITSUBISHI GAS CHEMICAL COMPANY, INC.
    Inventors: Genki Sugiyama, Kohei Yoshiya, Hidetaka Shimizu, Shun Ishikawa, Hiroyoshi Maruyama
  • Patent number: 11466133
    Abstract: The present invention provides a display substrate polyimide film having: remarkably improved insulation characteristics; inner pores, included in the polyimide film, of which the maximum size is 10 nm or less; and a high maximum dielectric breakdown voltage of 350 V/?m or more. The polyimide film according to the present invention has improved insulation characteristics so as to be capable of suppressing the generation of a current fluctuation of TFTs according to the long-term driving of a TFT device in a display such as an OLED, thereby enabling the deterioration of the contrast of a display to be reduced.
    Type: Grant
    Filed: February 7, 2020
    Date of Patent: October 11, 2022
    Assignee: LG CHEM, LTD.
    Inventors: Jinyoung Park, Danbi Choi, Ye Ji Hong